LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

Начало・Списък с акции・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Затворен

СекторЗдравеопазване

438.77 0.91

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

426.13

Максимум

440.48

Ключови измерители
By Trading Economics
Приходи	56M -59M
Продажби	34M 321M
Марж на печалбата	-18.243
Служители	915
EBITDA	56M -50M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+59.82% upside

Дивиденти
By Dow Jones
Следващи печалби	30.04.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-661M 9.9B
Предишно отваряне	437.86
Предишно затваряне	438.77

Настроения в новините

By Acuity

88%

12%

332 / 351 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

263.2 / 277.1 Подкрепа & съпротива

Madrigal Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.03.2026 г., 23:01 ч. UTC

Печалби

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

5.03.2026 г., 21:54 ч. UTC

Печалби

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

5.03.2026 г., 21:35 ч. UTC

Значими двигатели на пазара

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

6.03.2026 г., 00:00 ч. UTC

Значими събития в новините

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

5.03.2026 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

5.03.2026 г., 23:33 ч. UTC

Пазарно говорене

Gold Edges Higher on Possible Technical Recovery -- Market Talk

5.03.2026 г., 23:27 ч. UTC

Пазарно говорене

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

5.03.2026 г., 22:54 ч. UTC

Пазарно говорене

Печалби

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

5.03.2026 г., 22:50 ч. UTC

Пазарно говорене

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

5.03.2026 г., 22:48 ч. UTC

Печалби

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

5.03.2026 г., 22:46 ч. UTC

Печалби

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

5.03.2026 г., 22:44 ч. UTC

Печалби

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5.03.2026 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

5.03.2026 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

5.03.2026 г., 21:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

5.03.2026 г., 21:35 ч. UTC

Печалби

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5.03.2026 г., 21:32 ч. UTC

Печалби

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5.03.2026 г., 21:26 ч. UTC

Печалби

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

5.03.2026 г., 21:24 ч. UTC

Печалби

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

5.03.2026 г., 21:23 ч. UTC

Печалби

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

5.03.2026 г., 21:22 ч. UTC

Печалби

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5.03.2026 г., 21:21 ч. UTC

Печалби

Costco February Digitally-Enabled Sales Rose 21.8% >COST

5.03.2026 г., 21:21 ч. UTC

Печалби

Costco Total Co Comparable Sales for February Rose 7.9% >COST

5.03.2026 г., 21:20 ч. UTC

Печалби

Costco February Net Sales Were $21.69 B >COST

5.03.2026 г., 21:20 ч. UTC

Печалби

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5.03.2026 г., 21:20 ч. UTC

Печалби

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5.03.2026 г., 21:19 ч. UTC

Печалби

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

5.03.2026 г., 21:18 ч. UTC

Печалби

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

5.03.2026 г., 21:18 ч. UTC

Печалби

Costco 2Q Same-Store Sales Up 7.4% >COST

5.03.2026 г., 21:15 ч. UTC

Печалби

Costco 2Q EPS $4.58 >COST

Сравнение с други в отрасъла

Ценова промяна

Madrigal Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

59.82% нагоре

12-месечна прогноза

Среден 694.9 USD 59.82%

Висок 964 USD

Нисък 529 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за Madrigal Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

Купи

Задържане

Продай

Според 11 анализатори, дали борсови рейтинги на Madrigal Pharmaceuticals Inc през последните 3 месеца.

Техническа оценка

By Trading Central

263.2 / 277.1Подкрепа & съпротива

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Настроение

By Acuity

332 / 351 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.